Effect of Zoledronic Acid on Oral Fibroblasts and Epithelial Cells: A Potential Mechanism of Bisphosphonate-Associated Osteonecrosis

Por Scheper, MA, Badros, A, Chaisuparat, R, Cullen, KJ, Meiller, TF
Publicado em 2008

A Tumor Growth Inhibition Model Based on M‐Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single‐Agent Carfilzomib Use

Por Jonsson, F, Ou, Y, Claret, L, Siegel, D, Jagannath, S, Vij, R, Badros, A, Aggarwal, S, Bruno, R
Publicado no CPT Pharmacometrics Syst Pharmacol (2015)

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety

Por Badros, A Z, Vij, R, Martin, T, Zonder, J A, Kunkel, L, Wang, Z, Lee, S, Wong, A F, Niesvizky, R
Publicado em 2013

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

Por Greenberg, A J, Philip, S, Paner, A, Velinova, S, Badros, A, Catchatourian, R, Ketterling, R, Kyle, R A, Kumar, S, Vachon, C M, Rajkumar, S V
Publicado no Blood Cancer J (2015)

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

Por Greenberg, A J, Philip, S, Paner, A, Velinova, S, Badros, A, Catchatourian, R, Ketterling, R, Kyle, R A, Kumar, S, Vachon, C M, Rajkumar, S V
Publicado no Blood Cancer J (2015)

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy

Por Rapoport, AP, Meisenberg, B, Sarkodee-Adoo, C, Fassas, A, Frankel, SR, Mookerjee, B, Takebe, N, Fenton, R, Heyman, M, Badros, A, Kennedy, A, Jacobs, M, Hudes, R, Ruehle, K, Smith, R, Kight, L, Chambers, S, MacFadden, M, Cottler-Fox, M, Chen, T, Phillips, G, Tricot, G
Publicado no Bone Marrow Transplant (2002)